Skip to main content

Neogen Corporation

corporate_fare Company Profile

Neogen Corporation

NEOG·NASDAQ·Life Sciences·CIK 0000711377

NEOGEN CORP develops, manufactures, and markets a diverse line of products and services focused on food and animal safety. The company operates through two primary segments: Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary products, such as culture media. These products are sold to food and animal feed producers and processors to maintain food safety and quality, preventing contamination and foodborne illnesses caused by pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. They also ensure general hygiene in food manufacturing environments and determine food quality and nutritional components. Most test kits are consumable, single-use culture, immunoassay, and nucleic acid detection products utilizing proprietary antibodies and RNA and DNA testing methodologies for rapid and accurate results. Food safety services also include advanced software systems for objective analysis, storage, and identification of emerging issues from test results across multiple locations over extended periods. The Animal Safety segment develops, manufactures, markets, and distributes veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, insect control products, and genomics testing services for the global animal safety market. Most of these consumable products are marketed through veterinarians, retailers, livestock producers, and animal health product distributors. The company's drug detection products are sold worldwide for detecting abused and therapeutic drugs in animals and animal products, and have expanded into workplace testing and human forensic markets. In July 2025, NEOGEN CORP divested its global Cleaners and Disinfectants business. NEOGEN CORP's products are marketed globally by its sales personnel and distributors.

Neogen Corporation (NASDAQ:NEOG) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for NEOG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-07, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for NEOG spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Neogen Q1 FY2027: Revenue Up 6.5%, Operating Loss Narrows to $1.8M, Genomics Sale Still Pending
  • Neogen Lifts FY2027 Outlook on Q1 Beat and New Imaging Partnership
  • Neogen Q1 Revenue Beats, Raises FY27 Guidance on Strong Core Growth
  • FDA Warning Letter: Neogen's Hycoat Linked to 20 Horse Deaths, Contamination Found
  • Annual Report Highlights Significant Net Loss Reduction, Internal Control Remediation, and Debt Reduction

Financial Snapshot

Fiscal year ended May 31, 2026
Revenue
$870.4M
Net Income
-$7.9M
Diluted EPS
-$0.04
Op. Cash Flow
$83.2M
Free Cash Flow
$31.9M
Gross Profit
$408.5M
Operating Income
-$21.6M
Cash & Equivalents
$185.5M
Total Debt
$793.7M
Debt / Equity
0.38×
Net Margin
-0.9%
Shares Outstanding
217.7M sh
Source: 10-K · filed 2026-07-30 · accession 0001193125-26-326092

Short Interest & Short Volume

4.79 days to cover

FINRA reported short interest of 12,709,583 shares in NEOG as of the October 30, 2026 settlement, a 6.6% increase from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 58.0% of NEOG volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)12,709,583 shares as of October 30, 2026
Change vs prior period▲ 6.6%
Days to cover4.79 at avg daily volume of 2,654,184
Daily short volume (FINRA facilities)58.0% of 627,154 shares on November 20, 2026
5-day average short volume70.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with N →
$10.4 -1.42% today
52-week range · as of 2026-10-07 $5.37 – $14.26
Market cap
$2.3B
Volume
3M (1.1× avg)
3-mo avg 2.8M
Live data · 2026-11-22 04:04 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NEOG - Latest Insights

NEOG
Oct 07, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.68
Real-time Price: $10.40 info
Change: -$1.28 (-11%) info
Market Cap: $2.303B info
NEOG
Oct 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.56
Real-time Price: $10.40 info
Change: -$2.16 (-17%) info
Market Cap: $2.303B info
NEOG
Oct 06, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $11.99
Real-time Price: $10.40 info
Change: -$1.59 (-13%) info
Market Cap: $2.303B info
NEOG
Sep 29, 2026, 11:12 AM EDT
Source: Seeking Alpha
Importance Score:
8
Updated Sep 29, 3:49 PM ET — Neogen shares fell 4.85% to $13.06 on Tuesday following the FDA warning letter.
Price at Filing: $13.46
Real-time Price: $10.40 info
Change: -$3.06 (-23%) info
Market Cap: $2.303B info
NEOG
Jul 30, 2026, 4:04 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $11.46
Real-time Price: $10.40 info
Change: -$1.06 (-9%) info
Market Cap: $2.303B info
NEOG
Jul 30, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.57
Real-time Price: $10.40 info
Change: +$0.830 (+9%) info
Market Cap: $2.303B info
NEOG
Apr 09, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.04
Real-time Price: $10.40 info
Change: +$0.365 (+4%) info
Market Cap: $2.303B info
NEOG
Apr 09, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $9.47
Real-time Price: $10.40 info
Change: +$0.930 (+10%) info
Market Cap: $2.303B info
NEOG
Apr 09, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.11
Real-time Price: $10.40 info
Change: +$0.290 (+3%) info
Market Cap: $2.303B info
NEOG
Mar 30, 2026, 8:19 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.80
Real-time Price: $10.40 info
Change: +$1.60 (+18%) info
Market Cap: $2.303B info
NEOG
Mar 02, 2026, 8:58 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $11.47
Real-time Price: $10.40 info
Change: -$1.07 (-9%) info
Market Cap: $2.303B info
NEOG
Jan 08, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $9.65
Real-time Price: $10.40 info
Change: +$0.7499 (+8%) info
Market Cap: $2.303B info
NEOG
Jan 08, 2026, 7:03 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.32
Real-time Price: $10.40 info
Change: +$2.08 (+25%) info
Market Cap: $2.303B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets